Table 6 Total treatment costs for with and without SEB scenarios in year 3
Patient type (CKD stage) | Treatments for anemia | Year 3 total costs ($) | |
|---|---|---|---|
Without SEB | With SEB | ||
Stage III/IV | Short acting ESA (SC) | 35,043,965 | 26,219,895 |
Long acting ESA (SC) | 36,453,512 | 27,274,518 | |
Epoetin SEB | - | 7,807,525 | |
Stage V | Short acting ESA (SC) | 28,414,572 | 21,259,783 |
Long acting ESA (SC) | 19,676,765 | 14,722,155 | |
Short acting ESA (IV) | 116,734,773 | 87,340,957 | |
Long acting ESA (IV) | 81,175,581 | 60,735,569 | |
Epoetin SEB | - | 26,863,384 | |
Total | 317,499,168 | 272,223,786 | |